about
MicroRNA miR-155 is a biomarker of early pancreatic neoplasiaA series of 64 cases of pancreatic cystic neoplasia from an institutional study of ChinaBiological approaches to therapy of pancreatic cancer.MUC2 polymorphisms are associated with endometriosis development and infertility: a case-control study.A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.Gene expression patterns in human placentaPrognostic significance of P27 (Kip 1) and MUC1 in papillary transitional cell carcinoma of the urinary bladder.Mucinous urothelial carcinoma of the renal pelvis.Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 casesTumor-infiltrating neutrophils in pancreatic neoplasia.MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas.Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapyMUC1 regulates PDGFA expression during pancreatic cancer progressionMultiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy.Immunohistochemical features of the gastrointestinal tract tumorsMolecular targeted approaches for treatment of pancreatic cancer.Expression of MUC1 and its significance in hepatocellular and cholangiocarcinoma tissueAGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia.New tumor-associated antigen SC6 in pancreatic cancer.What is recent in pancreatic cancer immunotherapy?Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome.MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genesMultifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.Monoclonal antibodies in the treatment of pancreatic cancer.Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration.The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer.Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.Proteome Characterization of Human Pancreatic Cyst Fluid from Intraductal Papillary Mucinous Neoplasm by LC/MS/MS.A proteomic comparison of formalin-fixed paraffin-embedded pancreatic tissue from autoimmune pancreatitis, chronic pancreatitis, and pancreatic cancer.The intestinal glycome and its modulation by diet and nutrition.Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases.T cell optimization for the treatment of pancreatic cancer.Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas.Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis.Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells.Expression of MUC1 and MUC2 in ampullary cancer.Clinical and prognostic significance of MUC1 expression in patients with esophageal squamous cell carcinoma after radical resection.
P2860
Q24649254-EF7A5D83-E30B-47AD-893E-8DC942F0295CQ33866549-CDE44D9A-65AD-4625-8648-E65461BCB44AQ33899938-C746724E-BBAA-4D86-8214-500499D2D874Q34195190-EDD94E93-FB43-4B99-9706-B0827518DF82Q34335982-3E11FDCC-DE87-45EA-8A96-1A81A106D567Q34481691-C98D6118-180B-4E04-AA30-46399DB612EFQ34565890-984B0B93-A49F-475A-9E63-9891C635D720Q34760475-80DC17C9-CCC9-4F69-83EB-7C18FCD454C1Q35201034-A8D24564-BD05-452C-AB9B-2DA20B66B046Q35583287-FD21F56E-53BC-4224-A6F4-32C6FA83F108Q35589094-A66C0ABA-86E6-4A8E-B532-AC99CB32F4F1Q35886496-3577E3DC-5536-4FDE-97D5-3A30ED128535Q35916552-6C508584-1FCC-4C85-82F3-A65205CBE8AAQ35923257-9D4D0D00-6FF6-4E3A-9AF8-7F879D1F8EC8Q36162498-3A5775F0-8A24-469A-96B3-8ADA8ABE410FQ36174910-C51FE8CA-3FDA-4945-8AD7-A7C4437B7C44Q36190339-42958671-02FD-4B9F-8E18-A73BE67E36EFQ36449039-F43D4925-4C01-49BF-8D25-7D483273B56FQ36503356-6081D74C-759D-4009-843B-C82AAA10D2F1Q36665335-4A07890C-0F00-439C-BE7D-93A215DF48F2Q36919864-43D5D4D4-27B1-4B23-B234-0DD01D6D25A6Q37059144-981F4761-1D1A-47F7-8C70-35779E34AFEDQ37087112-301ACE88-E722-4226-BD8E-C6D890704C30Q37352325-3FC11C62-604E-4348-A91F-EB28D17086ECQ37355568-FBD1FB40-4376-4D42-AA47-BA14A0080101Q37381597-4A199945-780F-4B52-A7CB-C942A7500662Q37434103-89197217-0955-49E3-8F8C-7B58180FF6E0Q37438142-5BFA51EC-18C0-414A-8E3A-75664E500010Q38372053-C4668738-EA28-4947-9FAA-54EF26490D71Q38395698-ECBDB230-3BE3-45D6-92FB-F9E19FCE6313Q38503059-CAA821A6-9401-4E48-A371-2637532EEAC7Q38560347-B9D87A66-84CC-4CFE-B1C6-D8E465671010Q38638035-01D9BD88-B9C6-4807-B696-349A63FB0442Q41130771-7A98F6D4-5AEE-43D9-B8ED-3DC511AD7CDFQ42220466-0147B8BA-BC2E-45B4-AADC-FC1580B6FBB7Q42721594-5A547B75-3D8A-4A6E-9F53-0F15EC27AE18Q48237710-F2F8FEE9-449B-4AB5-9CD5-E84062F5B015Q51025367-CADEB796-9D38-471F-9E79-F9576B602B35Q55332318-D2E02561-D229-4234-BB1E-F49FC7699EB5
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
MUC1 and MUC2 in pancreatic neoplasia
@ast
MUC1 and MUC2 in pancreatic neoplasia
@en
type
label
MUC1 and MUC2 in pancreatic neoplasia
@ast
MUC1 and MUC2 in pancreatic neoplasia
@en
prefLabel
MUC1 and MUC2 in pancreatic neoplasia
@ast
MUC1 and MUC2 in pancreatic neoplasia
@en
P2093
P2860
P356
P1476
MUC1 and MUC2 in pancreatic neoplasia
@en
P2093
P2860
P304
P356
10.1136/JCP.2003.013292
P407
P577
2004-05-01T00:00:00Z